Search - tctmd.com

Displaying 41 - 60 of 121

Sort: Relevancy | Date

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Presenter: Gregg Stone

February 25, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? A Surgeon’s Viewpoint

Presenter: Mario Gaudino

February 25, 2022

News Features

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Yael L. Maxwell

January 21, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

L.A. McKeown

November 15, 2021

Presentation TCT 2021

TCT 101: Long-term Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Treating In-stent Restenosis in Unprotected Left Main Coronary Artery: Multicenter LM-DRAGON Registry

Presenter: Wojciech Wojakowski

November 05, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Conference News EHRA 2021

ICD Implant Commonly Brings Anxiety, Depression

Todd Neale

April 30, 2021

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Conference News SCAI 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

Caitlin E. Cox

May 20, 2020

Presentation SCAI 2020

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Presenter: Sripal Bangalore

May 16, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

News Daily News

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

Shelley Wood

December 20, 2019

Presentation Cardiovascular Interventions 2019

PCI Vs CABG for Multivessel and Unprotected LM Disease

Presenter: Paul S. Teirstein

November 01, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

Presentation TCT 2019

DEFINE-LM Registry: Revascularization Deferral in Patients With Left Main Coronary Artery Disease Based on iFR Evaluation

Presenter: Takayuki Warisawa

September 28, 2019

Advertisement

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? A Surgeon’s Viewpoint

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

TCT 101: Long-term Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Treating In-stent Restenosis in Unprotected Left Main Coronary Artery: Multicenter LM-DRAGON Registry

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

ICD Implant Commonly Brings Anxiety, Depression

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

PCI Vs CABG for Multivessel and Unprotected LM Disease

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

DEFINE-LM Registry: Revascularization Deferral in Patients With Left Main Coronary Artery Disease Based on iFR Evaluation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content